NFKB1 and breast neoplasm: Furthermore, nuclear NF-κB transcriptional machinery is disrupted in breast tumors resistant to SERM after estrogen treatment, potentially indicating that inhibition of NF-κB may be one of the pathways by which estrogen promotes apoptosis in breast tumor cells (126).